Wells Fargo & Company Organogenesis Holdings Inc. Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 30,822 shares of ORGO stock, worth $92,157. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,822
Previous 24,411 26.26%
Holding current value
$92,157
Previous $69,000 24.64%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$2.28 - $3.03 $14,617 - $19,425
6,411 Added 26.26%
30,822 $86,000
Q1 2024

May 10, 2024
BUY
$2.61 - $4.49 $8,198 - $14,103
3,141 Added 14.77%
24,411 $69,000
Q4 2023

Feb 09, 2024
BUY
$1.97 - $4.21 $8,396 - $17,943
4,262 Added 25.06%
21,270 $86,000
Q3 2023

Nov 13, 2023
SELL
$2.34 - $4.43 $23,538 - $44,561
-10,059 Reduced 37.16%
17,008 $54,000
Q2 2023

Aug 15, 2023
BUY
$1.9 - $4.3 $23,666 - $53,560
12,456 Added 85.25%
27,067 $89,000
Q1 2023

May 12, 2023
BUY
$1.89 - $2.93 $20,196 - $31,309
10,686 Added 272.25%
14,611 $31,000
Q4 2022

Feb 13, 2023
SELL
$2.48 - $3.43 $5,446 - $7,532
-2,196 Reduced 35.88%
3,925 $10,000
Q3 2022

Nov 14, 2022
SELL
$3.14 - $6.43 $15,181 - $31,089
-4,835 Reduced 44.13%
6,121 $20,000
Q2 2022

Aug 12, 2022
SELL
$4.74 - $8.15 $953,005 - $1.64 Million
-201,056 Reduced 94.83%
10,956 $54,000
Q1 2022

May 16, 2022
BUY
$6.47 - $9.57 $30,887 - $45,687
4,774 Added 2.3%
212,012 $1.62 Million
Q4 2021

Feb 14, 2022
SELL
$9.02 - $13.5 $2.57 Million - $3.84 Million
-284,775 Reduced 57.88%
207,238 $1.92 Million
Q3 2021

Nov 15, 2021
BUY
$13.71 - $17.18 $3.72 Million - $4.67 Million
271,615 Added 123.24%
492,013 $7.01 Million
Q2 2021

Aug 16, 2021
SELL
$14.92 - $23.23 $147,320 - $229,373
-9,874 Reduced 4.29%
220,398 $3.66 Million
Q1 2021

May 13, 2021
BUY
$7.33 - $21.06 $1.22 Million - $3.52 Million
167,072 Added 264.35%
230,272 $4.2 Million
Q4 2020

Feb 09, 2021
BUY
$3.63 - $7.53 $120,624 - $250,221
33,230 Added 110.88%
63,200 $476,000
Q3 2020

Nov 05, 2020
BUY
$3.29 - $4.58 $31,472 - $43,812
9,566 Added 46.88%
29,970 $115,000
Q2 2020

Aug 13, 2020
BUY
$2.86 - $4.61 $28,702 - $46,265
10,036 Added 96.8%
20,404 $78,000
Q1 2020

May 14, 2020
BUY
$2.92 - $5.31 $30,274 - $55,054
10,368 New
10,368 $33,000

Others Institutions Holding ORGO

# of Institutions
122
Shares Held
60.5M
Call Options Held
28.8K
Put Options Held
27.9K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $391M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email